etoposide has been researched along with glutaminase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HC; Fan, JR; Huang, TH; Li, TK; Lo, SC; Peng, AL | 1 |
Chen, L; Cui, H; Deng, H; Fang, J; Guo, H; Kuang, P; Wang, X; Zhao, L | 1 |
2 other study(ies) available for etoposide and glutaminase
Article | Year |
---|---|
Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses.
Topics: Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Cell Survival; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA Damage; DNA Repair; DNA Replication; DNA Topoisomerases, Type II; DNA-Binding Proteins; Down-Regulation; Etoposide; Glutaminase; HCT116 Cells; Histones; Humans; Intracellular Signaling Peptides and Proteins; Poly-ADP-Ribose Binding Proteins; Proteasome Endopeptidase Complex; Protein Kinases; Protein Serine-Threonine Kinases; Replication Protein A; Topoisomerase II Inhibitors; Transcription, Genetic; Tumor Suppressor Protein p53 | 2008 |
Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Survival; Cisplatin; Culture Media; Dose-Response Relationship, Drug; Etoposide; Female; Glutaminase; Glutamine; Humans; Immunoblotting; Sulfides; Thiadiazoles; Triple Negative Breast Neoplasms | 2016 |